All
A Thank You to Nurses and the Support That Lasts Beyond Cancer Care
After cancer, lifelong infusions were tough — until nurse Angela’s care and kindness reminded me that true support can last long after treatment ends.
Eraglusib Combo Improves Survival in Metastatic Pancreatic Cancer
Eraglusib with gemcitabine and nab-paclitaxel achieved statistical significance in the first-line treatment of metastatic pancreatic ductal adenocarcinoma.
Imfinzi Regimen Improves Disease-Free Survival in Early Bladder Cancer
Imfinzi plus BCG induction and maintenance therapy showed a statistically and clinically meaningful improvement in DFS for some with bladder cancer.
Breaking Down Barriers to Diagnosis in AYA Patients With Lymphoma
Dr. Kara Kelly discusses some of the most common challenges faced by adolescent and young adult patients with lymphoma.
Biomarker Testing Remains Crucial for Young Patients With Lung Cancer
Biomarker testing is vital for all patients with lung cancer, especially younger individuals who have higher rates of actionable mutations.
How Cancer Care Teams Can Help With the Cessation of Smoking
Dr. Daniel J. Boffa shared how cancer care teams support patients in quitting smoking and how new data may guide improvements in high-smoking U.S. regions.
The OVATION 3 Study Initiates First Trial Site for Ovarian Cancer
The first trial site has been initiated in the pivotal phase 3 OVATION 3 study which will investigate IMNN-001 for newly diagnosed advanced ovarian cancer.
Celebrating Nurses Week: The Heart and Soul of Our Cancer Community
I’m 22 years out from breast cancer and forever grateful for the nurses who gave me not just treatment but friendship, laughter and a community of hope.
FDA Approves Avmapki Fakzynja Co-pack for KRAS Serous Ovarian Cancer
Treatment with the Avmapki Fakzynja Co-pack received accelerated FDA approval for previously treated low-grade serous ovarian cancer with KRAS mutations.
Danyelza Added to NCCN Guidelines for High-Risk Neuroblastoma
Danyelza is now a recommended treatment in NCCN guidelines for relapsed or refractory high-risk neuroblastoma, a type of brain cancer.
Navigating Lymphoma and Survivorship in Adolescents and Young Adults
Dr. Kara Kelly discusses the unique challenges that adolescent and young adult patients with cancer face following their diagnosis.
Honoring a Healer: Personal Care With National Impact
This is a joint nomination by Camille Moses and Dr. Estelamari Rodriguez.
Breaking Barriers: Why Increasing Lung Screening is Critical
Lung cancer remains the leading cause of cancer-related deaths in the U.S.
Lung Cancer Initiative Names New Chief Scientific Officer and Announces 2025 Research Award Recipients
LCI has appointed Neal Ready, MD, PhD, as its first Chief Scientific Officer.
Managing Lung Inflammation After Chemoradiation and Tagrisso
Dr. Suresh S. Ramalingam explains that patients with stage 3 lung cancer who undergo chemotherapy and radiation may develop radiation pneumonitis.
LCI Shows Support for Lung Cancer Research Funding at GO2 Voices Summit
Lung Cancer Initiative proudly participated in the GO2 Voices Summit held March 9–11, 2025, in Washington, DC.
How Quitting Smoking After a Cancer Diagnosis Can Boost Survival
Dr. Daniel J. Boffa discusses the link between smoking cessation and increase in survival for people who are active smokers and diagnosed with cancer.
A Nurse Who Became Family After a Cancer Diagnosis
Eric Z. cared for my sister and mentored me with compassion, wisdom and unwavering presence — shaping my path in nursing and life.
Cemsidomide Generates Results at Multiple Doses in Multiple Myeloma
Treatment with cemsidomide resulted in notable responses at multiple dose levels for patients with multiple myeloma
Enhertu Regimen Improves Responses in High-Risk HER2+ Breast Cancer
Treatment with an Enhertu regimen significantly improved pathologic complete responses for patients with high-risk HER2-positive early-stage breast cancer.
Breast Cancer Survivor Reflects on 30 Years, Urges Informed Decisions
After 30 years with breast cancer, I urge others to pause, reflect and choose care based on long-term wellbeing, not fear or pressure.
Fighting for Patients, Processes and Education
I would like to nominate Ashley Tullio, RN, for the Extraordinary Healer Award for Oncology Nursing.
The Importance of Personalized Treatment Approaches for Urologic Cancers
Dr. Armine Smith discusses the importance of personalized therapeutic approaches for the treatment of urologic cancers, such as bladder or kidney cancer.
Nurse’s Big Personality Makes Cancer Treatment More Bearable.
She wore a variety of bright sneakers and occasionally did a cha-cha-cha in them. Her laughter was contagious. Patients smiled. The other nurses smiled.
Givinostat Wins U.S. FDA Fast Track Designation for Patients With PV
Treatment with givinostat has received fast track designation from the United States Food and Drug Administration for patients with polycythemia vera.
First Patient With Advanced Lung Cancer Dosed With Peluntamig Combo
The first patient was dosed in the SKYBRIDGE study assessing peluntamig with Tecentriq for advanced small cell lung cancer and neuroendocrine carcinomas.
Delving Into the Braftovi Plus Erbitux FDA Approval for BRAF+ mCRC
Dr. Cathy Eng discusses data that led to the FDA approval of Braftovi and Erbitux plus chemo for metastatic colorectal cancer with a BRAF V600E mutation.
A Staunch Advocate For Radiation Oncology Nursing and Compassionate Care
Everyone knows someone who has been affected by cancer.
A Personalized Approach to Bladder Preservation in Urologic Cancers
Bladder preservation for bladder cancer requires balancing clinical factors and patient health with a personalized treatment plan.
Mitigating Peripheral Neuropathy During Cancer Treatment
Dr. Shirley D'Sa discusses the importance of catching peripheral neuropathy in patients with Waldenström macroglobulinemia early on and how to treat it.
